Gilead Sciences Chief Medical Officer Berger Dietmar’s option exercise left him with 19,785 shares, representing about 2.7% of his resulting holding. A separate forfeiture left him with 19,522 shares, while his derivative-securities holding reached 46,395. The transactions provide investors with updated ownership figures and a $144.81 per-share transaction value.

Key Highlights

  • Berger Dietmar’s derivative-securities holding stood at 46,395 after the option exercise.
  • The separate forfeiture was recorded at $144.81 per share.
  • The forfeiture represented about 1.3% of Berger Dietmar’s prior shareholding.

GILEAD SCIENCES, INC. (NASDAQ: GILD) Chief Medical Officer Berger Dietmar’s option exercise left him with 19,785 shares on Sep. 10, 2026. The transaction represented about 2.7% of his resulting shareholding. A separate transaction on the same date reduced his reported holding to 19,522 shares. The related per-share value was $144.81.

Berger Dietmar’s Updated Gilead Holdings

The option exercise was recorded under transaction code M. The separate forfeiture was recorded under transaction code F, with the shares valued at $144.81 per share. The exercise also concerned derivative securities. Following that transaction, Berger Dietmar held 46,395 derivative securities tied to GILEAD SCIENCES, INC. The exercise represented about 1.1% of his prior derivative-securities holding. The share forfeiture represented about 1.3% of Berger Dietmar’s prior shareholding. His reported common-share position after the option exercise was 19,785 shares, while the separate transaction left 19,522 shares. The transaction codes used here mean: F denotes shares withheld or delivered to cover taxes or an exercise price; M denotes the exercise or conversion of a derivative security.